| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -962 | -1,008 | -329 | -1,390 |
| Depreciation, amortization, and other | 1,294 | 1,303 | 1,454 | 2,957 |
| Loss on write down of impaired assets | NaN | 0 | 0 | 0 |
| Deferred income taxes | NaN | -809 | 0 | 0 |
| Gain on sale of equipment | NaN | 0 | NaN | NaN |
| Bargain purchase gain ri acquisition, net of deferred income taxes | NaN | 0 | 0 | 0 |
| Accretion of debt issuance costs | 21 | 23 | 24 | 79 |
| Non cash lease expense | 133 | 18 | 76 | 237 |
| Asset retirement obligations, related party | NaN | 0 | 0 | NaN |
| Accretion of unfavorable lease position | 5 | -53 | 26 | 53 |
| Income taxes payable | NaN | 0 | 0 | 0 |
| Stock-based compensation expense | 101 | 100 | 101 | 203 |
| Receivables | -1,003 | -1,396 | 2,727 | -772 |
| Prepaid expenses and other assets | 29 | 126 | -585 | -1,218 |
| Accounts payable and accrued liabilities | 400 | 94 | -34 | -1,015 |
| Related party liabilities | 319 | -1,708 | 2,613 | -698 |
| Lease liabilities | -126 | -40 | -66 | -179 |
| Net cash provided by operating activities | 2,149 | -704 | 1,671 | 2,131 |
| Cash received in excess of cash paid for ri acquisition | NaN | 0 | 0 | 0 |
| Proceeds from sale of equipment | NaN | 0 | NaN | NaN |
| Payment for purchases of property and equipment | 41 | -1,984 | 3,702 | 5,916 |
| Net cash used in investing activities | -41 | 1,984 | -3,702 | -5,916 |
| Principal payments on line of credit | NaN | 2,000 | 5,000 | 2,000 |
| Principal payments on long-term debt | 472 | 913 | 934 | 1,167 |
| Advances on line of credit | 0 | 0 | 2,000 | 7,000 |
| Long-term debt financing on purchase of property and equipment | NaN | 0 | 0 | 0 |
| Debt issuance costs long-term debt | NaN | 0 | 0 | 0 |
| Capital contribution non-controlling interests | 0 | 0 | 0 | 8 |
| Distributions to non-controlling interests | 125 | 0 | 21 | 0 |
| Net cash (used in) provided by financing activities | -597 | -2,913 | -3,955 | 3,841 |
| Net change in cash, cash equivalents, and restricted cash | 1,511 | -1,633 | -5,986 | 56 |
| Cash, cash equivalents, and restricted cash at beginning of period | 3,712 | 5,345 | 11,275 | NaN |
| Cash, cash equivalents, and restricted cash at end of period | 5,223 | 3,712 | 5,345 | NaN |
AMERICAN SHARED HOSPITAL SERVICES (AMS)
AMERICAN SHARED HOSPITAL SERVICES (AMS)